Newsletters

Ex Vivo Expanded Allogeneic Vδ2 T Cells Specifically Reduce Reservoirs of HIV-1 Following Latency Reversal

[JCI Insight] Researchers found expanded allogeneic Vδ2 T cells specifically eliminated HIV-infected CD4+ T cells and monocyte-derived macrophages, overcoming inherent resistance to killing by other cell types such as NK and CD8+ T cells.

Parenteral Vaccination with an Adjuvanted mRNA Vaccine Induces Protective Mucosal Immunity against Rotavirus in Neonatal Mice

[Science Translational Medicine] Researchers introduced a lipid nanoparticle platform that codelivers mRNA and the retinoic acid receptor agonist Am80, enabling antigen-specific mucosal immune responses in the gut via parenteral intramuscular vaccination.

Toward CAR T Cell Therapy: Perfecting CAR and Lipid Nanoparticle Design

[Nano Letters] The authors review the molecular and mechanistic principles underlying in vivo CAR-T cell therapy, emphasizing how these nanoscale design features govern CAR T cell production and functional performance in vivo.

Ablation of Prostaglandin E2 Signalling through Dual Receptor Knockout in CAR T Cells Enhances Therapeutic Efficacy in Solid Tumours

[Nature Biomedical Engineering] Investigators generated knockout CAR T cells double deficient for the PGE2 receptors EP2 and EP4 by CRISPR–Cas9 engineering.

Michel Sadelain Awarded BBVA Foundation Frontiers of Knowledge Prize for Revolutionizing Cancer Treatment with Cell Therapies

[Columbia University Irving Medical Center] Dr. Michel Sadelain has been awarded a BBVA Foundation Frontiers of Knowledge Prize in Biology and Biomedicine for revolutionizing cancer treatment with CAR-T cell therapy, which modifies a patient’s own T cells to seek and destroy cancer cells.

Development of Prostate-Specific Lysosome-Targeting Degraders

[Journal of the American Chemical Society] Scientists developed a prostate-specific lysosome-targeting degradation strategy using a prostate-specific membrane antigen (PSMA) as a lysosome-targeting receptor.

Treg-γδ T Cell Axis Determines Sexual Dimorphism in Hepatocarcinogenesis

[Nature Communications] Scientists revealed significant sexual dimorphism in Tregs. Compared with hepatocellular carcinoma in female mice/patients, tumors in male mice/patients are more enriched in Tregs.

SAICAR Drives T Regulatory Cell Differentiation and FOXP3 Maintenance to Promote Immunotherapy Resistance

[Cancer Research] Investigators identified the purine biosynthesis intermediate succinylaminoimidazole carboxamide ribose-5′-phosphate (SAICAR) as a key metabolic driver of Treg induction and resistance to anti–PD-1 immunotherapy.

The Distinct Roles of ROS in Tumor Immunity: From Mechanisms to Immunotherapeutic Applications

[Journal of Hematology & Oncology] Scientists highlight the differential redox sensitivities between tumor cells and key immune subsets. This differential sensitivity, where cytotoxic T cells are exhausted and immunosuppressive cells like Tregs thrive, is a fundamental mechanism of immune evasion.

Ulcerative Colitis: Signaling Pathways, Therapeutic Targets, and Interventional Strategies

[Signal Transduction and Targeted Therapy] The authors discuss several cellular processes, such as autophagy, endoplasmic reticulum stress, mitochondrial dysfunction, macrophage polarization, ferroptosis and the Th/Treg cell balance, which are associated with the occurrence and development of Ulceralive Colitis.

Identification and Validation of the Protective Gene BCAT2 Related to Amino Acid Metabolism in Idiopathic Pulmonary Fibrosis

[Clinical and Experimental Medicine] Experimental validation researchers confirmed the significantly downregulation of BCAT2 in the lung tissues of IPF patients and in TGF-β1-treated alveolar epithelial cells

Cold Inducible RNA Binding Protein Promotes Fibroblast Activation and Its Inhibition Represents a Potential Therapeutic Target in Pulmonary Fibrosis

[Scientific Reports] Scientists investigated cold-inducible RNA-binding protein's function using an in vivo bleomycin-induced pulmonary fibrosis mouse model via intratracheal administration and an in vitro model with primary lung fibroblasts.
spot_img